| LOVE Stock | | | CAD 0.78 0.08 11.43% |
This module uses fundamental data of Cannara Biotech to approximate its Piotroski F score. Cannara Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Cannara Biotech. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Cannara Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Cannara Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in income.
At this time, Cannara Biotech's
Short and Long Term Debt is fairly stable compared to the past year.
Long Term Debt To Capitalization is likely to climb to 0.34 in 2024, whereas
Net Debt is likely to drop slightly above 25.9
M in 2024. At this time, Cannara Biotech's
Capex To Operating Cash Flow is fairly stable compared to the past year.
PFCF Ratio is likely to climb to 20.01 in 2024, whereas
PTB Ratio is likely to drop 0.66 in 2024.
At this time, it appears that Cannara Biotech's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
8.0
Piotroski F Score - Inapplicable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Lower Leverage| Focus | |
| Change In Outstending Shares | |
Cannara Biotech Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Cannara Biotech is to make sure Cannara is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Cannara Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Cannara Biotech's financial numbers are properly reported.
Cannara Biotech F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Cannara Biotech's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Cannara Biotech in a much-optimized way.
Click cells to compare fundamentals
About Cannara Biotech Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Cannara Biotech Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cannara Biotech from analyzing Cannara Biotech's financial statements. These drivers represent accounts that assess Cannara Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cannara Biotech's important valuation drivers and their relationship over time.
| | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) |
| Market Cap | | 67.8M | 130.1M | 118.4M | 61.2M | 70.4M | 128.1M |
| Enterprise Value | | 72.9M | 142.8M | 154.6M | 103.0M | 118.4M | 143.2M |
About Cannara Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannara Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannara Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Cannara Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to
measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to
predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.